Sarcomatoid Carcinoma — Trials

Sarcomatoid Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

37 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02496208	Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors	active not recruiting	Phase 1	152	National Cancer Institute (NCI)NIH	1	Sep 10, 2026	clinicaltrials
NCT06866262	Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial	recruiting	Phase 1 / Phase 2	55	University of Michigan Rogel Cancer CenterOTHER	1	Jul 31, 2026